IP Library Granted Patent US 7,750,134
Granted Patent B2
US 7,750,134 · App. 10/301,533 · Granted Jul 6, 2010

Nucleic acids encoding microbial SUMO protease homologs

Assignee: Sanford-Burnham Medical Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,750,134
App. No.
10/301,533
Granted
Jul 6, 2010
Kind
B2
Abstract

The invention provides isolated SUMO-specific protease-like (or “SSP”) domain-containing polypeptides from microorganisms, including bacteria, protozoans and yeast, including Escherichia, Salmonella, Pseudomonas, Chlamydia, Plasmodium, Trypanosma, Mesorhizobium, Rickettsia, Cryptosporidium and Candida species. The invention further provides modifications of such polypeptides, functional fragments therefrom, encoding nucleic acid molecules and specific antibodies. Also provided are methods for identifying polypeptides and compounds that associate with or modulate the activity of the SSP domain-containing polypeptides. Further provided are methods of modulating a biological activity in a cell, and treating pathological conditions, using the described nucleic acid molecules, polypeptides and compounds.

Claims (9)

1. An isolated nucleic acid molecule encoding a SUMO-specific protease-like domain (SSP domain) consisting of the amino acid sequence designated SEQ ID NO:27.

2. The nucleic acid molecule of claim 1 , operatively linked to a promoter of RNA transcription.

3. A vector comprising the nucleic acid molecule of claim 1 .

4. An isolated cell comprising the nucleic acid molecule of claim 1 .

5. The isolated cell of claim 4 , selected from the group consisting of a mammalian, a yeast and a bacterial cell.

6. The isolated cell of claim 5 , wherein the isolated cell is a mammalian cell.

7. The isolated cell of claim 5 , wherein the isolated cell is a yeast cell.

8. The isolated cell of claim 5 , wherein the isolated cell is a bacterial cell.

9. A method of producing a polypeptide comprising an SSP domain, comprising expressing the nucleic acid molecule of claim 1 in vitro or in an isolated cell under conditions suitable for expression of said polypeptide.

Assignments (4)
CHANGE OF NAME Recorded May 10, 2010
From: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
To: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
Reel/Frame 024362/0162 →
CHANGE OF NAME Recorded May 6, 2010
From: THE BURNHAM INSTITUTE
To: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
Reel/Frame 024348/0303 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Jun 4, 2008
From: THE BURNHAM INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021037/0992 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2003
From: GODZIK, ADAM; REED, JOHN C.
To: THE BURNHAM INSTITUTE
Reel/Frame 013729/0735 →
Continuity (2)
Provisional Application 6033189500 · Nov 20, 2001
Related Publication 20030203473A1 · Oct 30, 2003